Gold Nanoparticles as a Contrast Agent for In-Treatment Tumor Tracking
Byline
R Berbeco1 *, H Korideck2 , Y Yue1 , M Makrigiorgos1 , (1) Brigham and Women's Hospital, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, (2) Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA